Surprisingly, despite the central role of Cyclin D1 in cell cycle regulation, mice lacking Cyclin D1 are viable and resistant to HER2(neu)-induced breast cancers (but not to breast cancers induced by MYC) (138). Here, MYC is linked to breast carcinoma.